1. Home
  2. ATCH vs NNVC Comparison

ATCH vs NNVC Comparison

Compare ATCH & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AtlasClear Holdings Inc.

ATCH

AtlasClear Holdings Inc.

N/A

Current Price

$0.08

Market Cap

29.6M

Sector

N/A

ML Signal

N/A

NNVC

NanoViricides Inc.

N/A

Current Price

$1.43

Market Cap

33.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ATCH
NNVC
Founded
2022
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.6M
33.7M
IPO Year
2024
2008

Fundamental Metrics

Financial Performance
Metric
ATCH
NNVC
Price
$0.08
$1.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$1.00
★ $6.00
AVG Volume (30 Days)
★ 974.0K
157.6K
Earning Date
11-24-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 34.92
EPS
★ 0.02
N/A
Revenue
★ $20,052,635.00
N/A
Revenue This Year
$32.20
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.61
★ N/A
Revenue Growth
★ 84.70
N/A
52 Week Low
$0.13
$0.85
52 Week High
$0.38
$1.93

Technical Indicators

Market Signals
Indicator
ATCH
NNVC
Relative Strength Index (RSI) 18.09 53.39
Support Level N/A $1.23
Resistance Level $0.22 $1.49
Average True Range (ATR) 0.01 0.10
MACD -0.00 -0.01
Stochastic Oscillator 13.87 59.26

Price Performance

Historical Comparison
ATCH
NNVC

About ATCH AtlasClear Holdings Inc.

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company is engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific antiviral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing. The Company's platform is based on host-mimicry and thereby has uniquely enabled the development of broad-spectrum antiviral drugs that the viruses would be unable to escape, a critical unmet need in antiviral therapeutics.

Share on Social Networks: